| Identification | Back Directory | [Name]
2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol | [CAS]
180908-67-2 | [Synonyms]
LDL-IN-3
2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol
Phenol, 2,6-bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]- | [Molecular Formula]
C24H36O3Si | [MDL Number]
MFCD31380087 | [MOL File]
180908-67-2.mol | [Molecular Weight]
400.63 |
| Chemical Properties | Back Directory | [Boiling point ]
476.0±45.0 °C(Predicted) | [density ]
1.02±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
13.11±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
LDL-IN-3 is an anti-atherosclerotic compound extracted from patent WO/2005/039596A1, example C25 and patent US 6133467, example 3. | [in vivo]
LDL-IN-3 decreases serum cholesterol, TBARS and the amount of aortic lesions (57 %) in comparison with control rabbits. LDL-IN-3 is found in very high concentrations in the serum (182.4 μg/mL) and livers (323 μg/mL)[1][2]. | [storage]
Store at -20°C | [References]
[1] WO/2005/039596A1
[2] US 6133467 |
|
|